Engineering of synthetic gene circuits for the treatment of metabolic diseases
Open access
Author
Date
2013Type
- Doctoral Thesis
ETH Bibliography
yes
Altmetrics
Permanent link
https://doi.org/10.3929/ethz-a-010080191Publication status
publishedExternal links
Search print copy at ETH Library
Publisher
ETH-ZürichSubject
HYBRIDPROTEINE + REKOMBINANTE PROTEINE; GENREGULATION, REGULATION DER GENEXPRESSION (MOLEKULARBIOLOGIE); SYNTHETISCHE BIOLOGIE; APPETITZÜGLER (PHARMAZIE); BIOSENSOREN (BIOTECHNOLOGIE); GALLENSÄUREMETABOLISMUS (BIOCHEMIE); DOPAMIN (BIOCHEMIE); DOPAMINREZEPTOREN (NEUROLOGIE); REGULATION, STEUERUNG, KONTROLLE (BIOLOGIE); STOFFWECHSELKRANKHEITEN + STOFFWECHSELSTÖRUNGEN (PATHOLOGIE); HYBRID PROTEINS + RECOMBINANT PROTEINS; GENE REGULATION, REGULATION OF GENE-EXPRESSION (MOLECULAR BIOLOGY); SYNTHETIC BIOLOGY; ANOREXIANTS + ANORECTIC DRUGS (PHARMACY); BIOSENSORS (BIOTECHNOLOGY); BILE ACID METABOLISM (BIOCHEMISTRY); DOPAMINE (BIOCHEMISTRY); DOPAMINE RECEPTORS (NEUROLOGY); REGULATION, CONTROLE (BIOLOGY); METABOLIC DISORDERS (PATHOLOGY)Organisational unit
02214 - Biosystems Science and Engineering BSSE03694 - Fussenegger, Martin / Fussenegger, Martin
Notes
Diss., Eidgenössische Technische Hochschule ETH Zürich, Nr. 21499, 2013.More
Show all metadata
ETH Bibliography
yes
Altmetrics